Table 3 Annual changes in 1 year the antigen avoidance test
From: Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
Antigen avoidance test | p-value | ||
|---|---|---|---|
positive | Negative | ||
A. BEFORE | |||
delta FVC %pred (%) | − 6.5 ± 2.3 (n = 14) | − 0.3 ± 1.9 (n = 20) | 0.045 |
delta Serum KL-6 (%) | 32.5 ± 17.2 (n = 16) | 13.6 ± 9.9 (n = 21) | 0.32 |
delta White blood cell (%) | 13.3 ± 4.6 (n = 16) | − 1.4 ± 6.6 (n = 21) | 0.10 |
delta C-reactive protein (mg/dL) | − 0.08 ± 0.05 (n = 16) | 0.00 ± 0.07 (n = 21) | 0.66 |
B. AFTER | |||
delta FVC %pred (%) | 0.8 ± 1.5 (n = 15) | − 5.0 ± 2.4 (n = 20) | 0.048 |
delta Serum KL-6 (%) | − 27.2 ± 7.2 (n = 16) | − 5.2 ± 7.5 (n = 23) | 0.049 |
delta White blood cell (%) | 32.8 ± 10.6 (n = 16) | 29.6 ± 8.8 (n = 23) | 0.81 |
delta C-reactive protein (mg/dL) | 0.00 ± 0.04 (n = 16) | 0.08 ± 0.09 (n = 23) | 0.44 |